Laborie to Buy JADA System in $465 Million Deal

Laborie to Buy JADA System in $465 Million Deal

In a move poised to reshape the maternal health technology landscape, Laborie Medical Technologies announced plans to acquire the JADA System, a postpartum uterine bleeding device developed by Organon, for up to $465 million. The acquisition, unveiled Friday and guided by Simpson Thacher & Bartlett LLP and Cooley LLP, includes an upfront payment of $440 Laborie to buy JADA System for $465M, expanding its maternal health reach across global market

Organon divests JADA system to Laborie in $465m deal

Organon is selling its JADA post-partum haemorrhage (PPH) treatment system to Laborie Medical in a deal valued at up to $465m.The post Organon divests JADA system to Laborie in $465m deal appeared first on Medical Device Network.